Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sunshine Biopharma (SBFM) Inventory (2019 - 2025)

Historic Inventory for Sunshine Biopharma (SBFM) over the last 7 years, with Q3 2025 value amounting to $14.1 million.

  • Sunshine Biopharma's Inventory rose 4320.43% to $14.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $14.1 million, marking a year-over-year increase of 4320.43%. This contributed to the annual value of $11.3 million for FY2024, which is 9666.24% up from last year.
  • As of Q3 2025, Sunshine Biopharma's Inventory stood at $14.1 million, which was up 4320.43% from $13.0 million recorded in Q2 2025.
  • In the past 5 years, Sunshine Biopharma's Inventory registered a high of $14.1 million during Q3 2025, and its lowest value of $26660.0 during Q1 2021.
  • Its 5-year average for Inventory is $5.2 million, with a median of $4.3 million in 2023.
  • As far as peak fluctuations go, Sunshine Biopharma's Inventory soared by 301400.38% in 2022, and later soared by 4320.43% in 2025.
  • Sunshine Biopharma's Inventory (Quarter) stood at $105650.0 in 2021, then surged by 3014.0% to $3.3 million in 2022, then skyrocketed by 74.31% to $5.7 million in 2023, then surged by 96.66% to $11.3 million in 2024, then rose by 24.7% to $14.1 million in 2025.
  • Its last three reported values are $14.1 million in Q3 2025, $13.0 million for Q2 2025, and $11.9 million during Q1 2025.